This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Watson Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript

Watson Pharmaceuticals (WPI)

Q2 2012 Earnings Call

July 26, 2012 8:30 am ET

Executives

Lisa M. Defrancesco - Former Vice President of Global Investor Relations

Paul M. Bisaro - Chief Executive Officer, President and Director

R. Todd Joyce - Chief Financial Officer -Global

George Frederick Wilkinson - President of Global Brands and Biosimilars

Sigurdur Oli Olafsson - President of Global Generics

Analysts

Gregory B. Gilbert - BofA Merrill Lynch, Research Division

David Amsellem - Piper Jaffray Companies, Research Division

Marc Goodman - UBS Investment Bank, Research Division

David G. Buck - The Buckingham Research Group Incorporated

Timothy Chiang - CRT Capital Group LLC, Research Division

Christopher Schott - JP Morgan Chase & Co, Research Division

Jami Rubin - Goldman Sachs Group Inc., Research Division

Aaron Gal - Sanford C. Bernstein & Co., LLC., Research Division

Elliot Wilbur - Needham & Company, LLC, Research Division

Michael Faerm - Crédit Suisse AG, Research Division

Ken Cacciatore - Cowen and Company, LLC, Research Division

Gary Nachman - Susquehanna Financial Group, LLLP, Research Division

Michael Kallai Tong - Wells Fargo Securities, LLC, Research Division

David Risinger - Morgan Stanley, Research Division

Randall Stanicky - Canaccord Genuity, Research Division

Douglas D. Tsao - Barclays Capital, Research Division

Shibani Malhotra - RBC Capital Markets, LLC, Research Division

Presentation

Operator

Good morning. My name is Cassandra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Watson second quarter earnings call. [Operator Instructions]

And now, I would like to turn the call over to Lisa DeFrancesco, Vice President of Global Investor Relations.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs